This new publication provides post-marketing information to healthcare professionals to enhance communication of new drug safety information, raise awareness of reported adverse events, and stimulate additional adverse event reporting.
The U.S. Food and Drug Administration (FDA) described the risks of several medications in this new report published in its Drug Safety Newsletter for health care professionals.
The move came after the Institute of Medicine (IOM) sharply criticized the FDA in 2006, saying it has “a dysfunctional structure hindering its ability to protect public health.” The Agency has also been criticized for not monitoring drugs after they’re on the market.
The report, which fills one of the FDA’s commitments to the IOM after the criticism, details the side effects from a number of drugs…
Click Here To Read The Latest FDA Drug Safety Newsletter...
I recommend you add this page to your favourites so that you can keep up to date on new releases...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment